Profile data is unavailable for this security.
About the company
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
- Revenue in USD (TTM)75.60m
- Net income in USD-23.26m
- Incorporated1979
- Employees310.00
- LocationEdap Tms SAParc ActiviteLa Poudrette Lamartine4/6 Rue du DauphineVAULX-EN-VELIN 69120FranceFRA
- Phone+33 472153150
- Fax+33 472153151
- Websitehttps://focalone.com/fr/accueil/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LENSAR Inc | 59.14m | -51.52m | 146.08m | 140.00 | -- | -- | -- | 2.47 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 147.24m | 288.00 | 10.84 | 1.00 | 7.28 | 1.79 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| Apyx Medical Inc | 47.90m | -14.54m | 152.57m | 220.00 | -- | 24.06 | -- | 3.19 | -0.3644 | -0.3644 | 1.19 | 0.1546 | 0.8113 | 1.97 | 3.68 | 217,736.40 | -24.60 | -27.67 | -29.90 | -33.35 | 62.65 | 64.81 | -30.32 | -43.61 | 3.61 | -2.04 | 0.8507 | -- | -8.11 | 11.24 | -25.38 | -- | -11.11 | -- |
| InfuSystem Holdings Inc | 141.05m | 5.52m | 153.33m | 502.00 | 28.82 | 2.76 | 8.09 | 1.09 | 0.2616 | 0.2616 | 6.65 | 2.73 | 1.38 | 10.25 | 5.79 | 280,984.10 | 5.41 | 4.50 | 6.56 | 5.46 | 55.35 | 55.24 | 3.92 | 3.86 | 1.60 | 7.73 | 0.274 | 0.00 | 7.22 | 10.70 | 168.92 | 11.50 | -4.62 | -- |
| Cibus Inc | 3.79m | -118.90m | 156.17m | 157.00 | -- | 2.40 | -- | 41.16 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| Inogen Inc | 347.03m | -25.38m | 156.38m | 766.00 | -- | 0.7931 | -- | 0.4506 | -1.00 | -1.00 | 13.47 | 7.26 | 1.13 | 7.92 | 9.30 | 453,039.20 | -8.28 | -11.40 | -10.67 | -13.50 | 44.76 | 44.22 | -7.31 | -13.82 | 2.75 | -- | 0.00 | -- | 6.35 | -1.49 | 64.97 | -- | 38.15 | -- |
| Nano-X Imaging Ltd | 12.30m | -55.71m | 157.80m | 165.00 | -- | 0.9513 | -- | 12.83 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Acme United Corp | 194.96m | 10.02m | 168.37m | 633.00 | 18.17 | 1.45 | 10.36 | 0.8636 | 2.43 | 2.43 | 47.35 | 30.41 | 1.15 | 2.03 | 6.35 | 307,993.70 | 5.92 | 7.26 | 6.81 | 8.54 | 39.51 | 36.34 | 5.14 | 5.68 | 1.75 | 8.57 | 0.1962 | 18.40 | 1.56 | 6.42 | -43.67 | 12.70 | 33.59 | 4.56 |
| Citrine Global Corp | 0.00 | -1.74m | 169.70m | 18.00 | -- | -- | -- | -- | -0.0016 | -0.0016 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -118.80 | -238.43 | -- | -- | -- | -- | -- | -186,483.40 | -- | -2.10 | -- | -- | -- | -- | 25.99 | -- | -- | -- |
| Accendra Health Inc | 6.71bn | -410.53m | 173.26m | 13.50k | -- | -- | -- | 0.0258 | -5.33 | -17.41 | 86.97 | -5.56 | 1.47 | 7.59 | 15.52 | 496,837.20 | -9.01 | -0.3346 | -17.40 | -0.5248 | 26.13 | 18.20 | -6.12 | -0.146 | 0.8386 | 1.67 | 1.25 | -- | 3.55 | 3.04 | -778.15 | -- | 34.30 | -- |
| Rapid Micro Biosystems Inc | 30.52m | -44.29m | 173.30m | 163.00 | -- | 3.91 | -- | 5.68 | -0.9984 | -0.9984 | 0.6884 | 1.00 | 0.3209 | 1.33 | 6.40 | 187,257.70 | -46.56 | -38.13 | -56.14 | -43.36 | 7.72 | -27.98 | -145.11 | -253.02 | 2.95 | -- | 0.3003 | -- | 24.57 | 11.18 | 10.63 | -- | -4.24 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 174.13m | 72.00 | -- | -- | -- | 39.58 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
| Edap Tms SA (ADR) | 75.60m | -23.26m | 174.34m | 310.00 | -- | 6.31 | -- | 2.31 | -0.6212 | -0.6212 | 2.02 | 0.7391 | 0.9081 | 2.08 | 3.62 | 243,869.70 | -27.94 | -11.18 | -49.24 | -15.86 | 43.24 | 42.19 | -30.77 | -16.63 | 0.9729 | -- | 0.2062 | -- | 6.11 | 7.38 | 10.20 | -- | 55.92 | -- |
| Stereotaxis Inc | 30.07m | -24.91m | 185.72m | 139.00 | -- | 28.93 | -- | 6.18 | -0.281 | -0.281 | 0.3393 | 0.1266 | 0.6232 | 1.47 | 4.54 | 216,359.70 | -48.96 | -31.30 | -85.25 | -43.31 | 53.07 | 62.81 | -78.56 | -56.04 | 0.8108 | -- | 0.00 | -- | 0.5491 | -1.41 | -14.95 | -- | 2.89 | -- |
| OraSure Technologies Inc | 125.70m | -60.24m | 197.27m | 501.00 | -- | 0.549 | -- | 1.57 | -0.8107 | -0.8107 | 1.69 | 5.01 | 0.2834 | 2.07 | 4.91 | 250,904.20 | -13.08 | -0.8506 | -14.16 | -0.9596 | 40.41 | 44.80 | -46.15 | -1.39 | 6.20 | -- | 0.0005 | -- | -54.17 | 3.75 | -136.34 | -- | -16.43 | -- |
| Electromed Inc | 66.22m | 8.20m | 200.76m | 177.00 | 26.10 | 4.53 | 21.33 | 3.03 | 0.9295 | 0.9295 | 7.50 | 5.35 | 1.29 | 4.04 | 2.70 | 374,118.70 | 15.99 | 9.33 | 18.99 | 11.04 | 78.04 | 76.56 | 12.38 | 8.40 | 4.66 | -- | 0.00 | 0.00 | 16.97 | 14.53 | 46.35 | 12.62 | -20.72 | -- |
Data as of Feb 17 2026. Currency figures normalised to Edap Tms SA's reporting currency: US Dollar USD
35.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Soleus Capital Management LP (Investment Management)as of 31 Dec 2025 | 7.31m | 19.55% |
| Morgan Stanley & Co. International Plcas of 31 Dec 2025 | 3.35m | 8.97% |
| Rock Springs Capital Management LPas of 30 Sep 2025 | 1.27m | 3.40% |
| Bruce & Co., Inc.as of 31 Dec 2025 | 438.65k | 1.17% |
| UBS Securities LLCas of 31 Dec 2025 | 207.26k | 0.55% |
| Schonfeld Strategic Advisors LLCas of 30 Sep 2025 | 170.06k | 0.46% |
| Parkman Healthcare Partners LLCas of 30 Sep 2025 | 154.83k | 0.41% |
| Cahill Financial Advisors, Inc.as of 30 Sep 2025 | 134.96k | 0.36% |
| U.S. Bank NA (Cincinnati Ohio Investment Management)as of 31 Dec 2025 | 119.00k | 0.32% |
| Summit Trail Advisors LLCas of 30 Sep 2025 | 102.34k | 0.27% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
